Enclomiphene not working? 9 real reasons and what to check

Last updated 2026-07-30

What counts as "enclomiphene not working"?

Before troubleshooting anything, define the failure. Are we talking about testosterone levels that haven't moved on labs, or symptoms (energy, libido, mood) that haven't improved even though the numbers look better? These are different problems with different fixes. Most of the clinical data on enclomiphene comes from the Androxal development program, which tested doses of 12.5 mg and 25 mg daily in men with secondary hypogonadism. In one of the published Phase III trials, roughly 80-90% of men on enclomiphene reached normal total testosterone (over 300 ng/dL) by week 16, compared to under 20% on placebo ^[1]. That's a strong response rate. But it also means a meaningful minority of men don't normalize on standard dosing, and even among those who do, not everyone feels symptomatically better despite normal labs. So "not working" has at least three flavors: labs didn't move, labs moved but symptoms didn't, or labs moved partway but not enough to feel like TRT-level relief. Each points to a different next step, covered below. If you're still deciding whether enclomiphene is the right tool at all, enclomiphene reviews and the enclomiphene success rate page cover what "normal" response looks like before you assume something's broken.

How long does enclomiphene actually take to work?

Give it 6 to 8 weeks minimum before calling it a failure. Testosterone starts rising within the first couple weeks for most men, but the trials that support enclomiphene's use measured response at 6, 12, and 16 weeks, not at day 10 ^[1]. A lot of people check labs at 2-3 weeks, see testosterone still in the 400s, and conclude it's not working. That's premature. The hypothalamic-pituitary-gonadal axis needs time to ramp up LH and FSH output, and the testes need time to respond to that signal. Checking too early is probably the single most common reason people think enclomiphene has failed when it just hasn't finished working yet. If you're at week 8 or beyond with no change in LH, FSH, or total testosterone, that's a real signal something is off, not a timing issue. That's the point to get bloodwork and talk to whoever is managing your care rather than adjusting the dose yourself. For a week-by-week sense of what "on track" looks like, see the enclomiphene results timeline.

Is your dose too low or too high?

Enclomiphene dosing isn't one-size-fits-all, and both under- and over-dosing cause "it's not working" complaints, just for different reasons. The Androxal trials used 12.5 mg and 25 mg daily doses ^[1]. Most compounding pharmacies working with prescribers today land somewhere in that range, often starting at 12.5 mg and titrating up based on labs. If you're on a low dose (say 6.25 mg, which some clinics use) and your testosterone barely moved, the fix might just be more drug, not a different drug. But higher isn't automatically better. SERMs like enclomiphene work by blocking estrogen receptors in the hypothalamus, which the brain reads as "estrogen is low," prompting more GnRH, more LH and FSH, and more testosterone production ^[2]. Push the dose too high and some men develop side effects (visual disturbances, mood changes, worse sleep) without proportionally more testosterone gain, because the dose-response curve isn't linear for everyone. A dose that's working should show rising LH and FSH alongside rising total and free testosterone. If LH and FSH are up but total testosterone is flat, that's not a dosing problem, that's a testicular capacity problem (see below). Don't self-titrate. If your numbers are flat or your side effects are getting worse, that's a bloodwork-and-prescriber conversation, not a "try double the dose" decision.

Could the real problem be primary (not secondary) hypogonadism?

This is the single biggest reason enclomiphene fails outright: it was studied in men with secondary hypogonadism, and it does very little for primary hypogonadism. Secondary hypogonadism means the testes are fine but the signal from the pituitary (LH, FSH) is too weak. That's the population enclomiphene is designed for. It works by increasing that signal. Primary hypogonadism means the testes themselves are damaged or underperforming, whether from injury, prior anabolic steroid use, Klinefelter syndrome, chemotherapy, or age-related testicular decline. In primary hypogonadism, LH and FSH are already high (the pituitary is shouting at testes that can't respond), and giving enclomiphene just shouts louder into a system that isn't listening. Testosterone stays low no matter how much LH goes up. The giveaway is baseline labs. If your LH and FSH were already elevated before starting enclomiphene, and total testosterone was still low, that's a primary hypogonadism pattern. Enclomiphene isn't going to fix that, and no dose adjustment changes that fact. This is also why a full baseline panel (total T, free T, LH, FSH, plus estradiol and prolactin) before starting is not optional paperwork. It's the test that tells you whether enclomiphene has a reasonable chance of working at all.

Could it be the compounded product itself?

Enclomiphene is not FDA-approved as a standalone medication. The Androxal program (the branded enclomiphene citrate product developed by Repros Therapeutics) completed Phase III trials but never received FDA approval, and the sponsor's New Drug Application was not cleared for marketing ^[1][3]. What's available today is compounded enclomiphene, prepared by a compounding pharmacy under a physician's prescription, typically through Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act ^[4]. That distinction matters for troubleshooting. Compounded products aren't subject to the same batch-consistency testing as FDA-approved drugs. Potency variation between compounding pharmacies, and even between batches from the same pharmacy, is a real and documented concern with compounded medications generally ^[4]. If your labs show zero hormonal response at a dose that should be doing something (LH and FSH completely flat at week 8, for instance), a legitimately underdosed or degraded product is a reasonable thing to suspect, not paranoia. This is one of the practical reasons to use a pharmacy that does third-party potency testing and to work with a telehealth provider who reviews labs rather than a source with no clinical oversight. If you switch pharmacies and the same dose suddenly produces a real hormonal response, that tells you something about the first product. This is also where Enclomiphene Direct fits into the picture: it's a provider-reviewed pathway that connects you to a prescriber and a fulfilling pharmacy partner, rather than an anonymous supplement seller. It doesn't compound or manufacture anything itself; it coordinates the clinical and pharmacy side so you're not guessing about what's in the vial.

Are you taking it consistently, and at the right time?

Missed doses and inconsistent timing blunt the hormonal signal enclomiphene depends on. Because it works through a feedback loop (block estrogen receptor signaling, prompt more GnRH/LH/FSH, prompt more testosterone), skipping days means the loop keeps resetting instead of building. Most protocols use once-daily dosing, often in the morning, though there's no strong evidence that time-of-day matters much for a drug with roughly a 10-hour half-life range reported in early pharmacokinetic studies of enclomiphene ^[5]. What matters more is not skipping days. If you're taking it "most days" or forgetting for a week here and there, don't be surprised if labs look unimpressive at your 8-week check. Alcohol, major sleep disruption, and acute illness in the days before a blood draw can also shift testosterone independent of the drug. If your "not working" lab draw happened during a rough week (poor sleep, a cold, heavy drinking the night before), that single data point may not reflect what the drug is actually doing. Repeat the test under normal conditions before concluding anything.

Enclomiphene vs. clomiphene: could the confusion itself be the problem?

Enclomiphene and clomiphene are related but not identical, and mixing them up in your head (or your pharmacy mixing them up in a compound) can explain confusing results. Clomiphene citrate (brand name Clomid) is actually a mixture of two isomers: enclomiphene and zuclomiphene, roughly in a 62:38 ratio ^[6]. Enclomiphene is the isomer responsible for most of the anti-estrogenic, LH/FSH-boosting effect. Zuclomiphene is a weaker, longer-acting isomer that some researchers believe contributes to side effects like mood changes and visual disturbances with less benefit for testosterone ^[2][6]. So "enclomiphene" as a compounded product is meant to be the isolated, more active isomer, without the zuclomiphene along for the ride. If you were previously on clomiphene (common in fertility clinics for men, off-label) and switched to enclomiphene expecting an identical experience, some difference in side effect profile and possibly response is expected, since you're no longer getting the zuclomiphene component at all. If you suspect what you were sold as "enclomiphene" might actually be full clomiphene relabeled, or a compound with an unclear isomer ratio, that's worth raising directly with the pharmacy, since it would explain both unexpected side effects and unexpected lab results.

Could something else be causing your low testosterone symptoms?

Enclomiphene only fixes low testosterone that's driven by inadequate LH/FSH signaling. It does nothing for the other common causes of "low T symptoms." Thyroid dysfunction, especially hypothyroidism, causes fatigue, low libido, and weight gain that mimic hypogonadism symptoms even when testosterone is fine or only mildly reduced. Elevated prolactin, from a pituitary microadenoma or certain medications, suppresses GnRH and can blunt the entire axis enclomiphene is trying to stimulate. Obesity and poor sleep (especially untreated sleep apnea) are independently associated with lower testosterone and are common enough that they should be ruled out, not assumed away, before blaming a medication. If your prolactin is high, elevated prolactin itself can suppress testosterone through the same hypothalamic pathway enclomiphene is trying to stimulate, so treating the prolactin problem first (or alongside) often matters more than adjusting the enclomiphene dose. A full baseline panel that includes TSH, prolactin, and often a fasting glucose or A1C is the reasonable standard of care before and during enclomiphene use, more than testosterone and LH/FSH.

Labs improved but you still feel bad. Why?

This is common and frustrating: total testosterone normalizes, but energy, mood, or libido don't follow. A few explanations show up repeatedly in clinical discussion of hypogonadism treatment generally, even though enclomiphene-specific data on this exact question is limited. Free testosterone, not total, is what tissues actually use. Sex hormone-binding globulin (SHBG) can be high enough that total testosterone looks normal while free testosterone stays low. If your provider only checked total T, ask for free T (or calculated free T) on the next panel. Estradiol matters too. Enclomiphene raises testosterone, and some of that testosterone aromatizes into estradiol. Men who swing too low or too high on estradiol can feel worse even with "good" testosterone numbers. This is a real reason to track estradiol alongside testosterone, more than assume more T is always better. And symptom improvement genuinely lags lab improvement for some men by weeks, not days. The enclomiphene before and after accounts and the enclomiphene results timeline both show this pattern: numbers often move before the felt experience catches up.

What labs should you actually check if enclomiphene isn't working?

At minimum: total testosterone, free testosterone (or calculated free T with SHBG), LH, FSH, estradiol, and prolactin. If baseline symptoms suggest it, add TSH and a metabolic panel. The pattern in your labs tells you where to look next. | Lab pattern | Likely explanation |

Does enclomiphene actually preserve fertility, and does that change if it's "not working"?

Fertility preservation is the main reason men choose enclomiphene over exogenous testosterone in the first place, and it's worth being precise about what the evidence actually shows. Exogenous TRT (injections, gels, pellets) suppresses LH and FSH by signaling to the brain that testosterone is already sufficient. That suppression shuts down the testes' own production and sperm production along with it, which is why testicular shrinkage and reduced fertility are well-documented effects of TRT . Enclomiphene works the opposite direction: it blocks estrogen feedback at the hypothalamus, which increases LH and FSH rather than suppressing them, so testicular function and sperm production are expected to continue rather than shut down ^[1][2]. That mechanistic logic is solid and is the reason reproductive endocrinologists and fertility-focused urologists often prefer enclomiphene or clomiphene over TRT for men who want to preserve fertility while treating low testosterone. But it's worth being honest about the evidence gap: the Androxal trials were designed and powered around testosterone and symptom endpoints, not pregnancy or live sperm count outcomes, and there is no large enclomiphene-specific trial proving improved pregnancy rates ^[1]. The fertility-preservation claim rests on hormonal mechanism (LH/FSH stay up, testes stay stimulated) and on decades of clinical experience with clomiphene in male infertility, not on a dedicated enclomiphene fertility outcomes trial. If enclomiphene "isn't working" for testosterone specifically, that doesn't necessarily mean it's failing at fertility preservation, since those are measured differently (semen analysis and testicular size versus testosterone level). If fertility is your primary goal and testosterone response is disappointing, that's a conversation for a reproductive urologist, not a reason to assume the fertility benefit has failed too.

When should you stop and consider switching, or trying TRT instead?

If you've given it 12-16 weeks at an appropriate dose, confirmed the product with a second pharmacy or a potency-tested source, ruled out primary hypogonadism, thyroid and prolactin problems, and your total and free testosterone are still not improving, that's a legitimate point to reconsider the plan. Some men are simply better responders to TRT than to a SERM, particularly those with primary hypogonadism where SERMs have limited biological room to work. Others do fine on enclomiphene once dose, product quality, and comorbidities are sorted out. There's no way to know in advance which category you're in; that's what the trial period and labs are for. Weigh this decision against your actual goals. If preserving fertility or testicular size matters to you, a genuine non-response to enclomiphene after appropriate troubleshooting is a real cost to factor in, since TRT trades fertility preservation for a more reliable testosterone bump. The enclomiphene pros and cons page and is enclomiphene worth it cover that tradeoff directly, and are worth reading before switching lanes.

Frequently asked questions

How long before enclomiphene starts working?

Testosterone typically starts rising within 2-4 weeks, but the trials supporting enclomiphene's use measured meaningful response at 6, 12, and 16 weeks ^[1]. Don't judge it as "not working" before 6-8 weeks of consistent use with a follow-up lab panel.

Why is my testosterone still low on enclomiphene?

Common reasons: dose too low, product underdosed or inconsistent (it's compounded, not FDA-approved), primary rather than secondary hypogonadism (LH/FSH already high at baseline), or a coexisting issue like high prolactin or thyroid dysfunction. Bloodwork with LH, FSH, and prolactin usually identifies which.

Can enclomiphene fail completely for some men?

Yes. In the Phase III trials that support its use, a meaningful minority of men on enclomiphene did not reach normal total testosterone by week 16, versus roughly 80-90% who did ^[1]. Primary hypogonadism is the most common reason for near-total non-response.

Is enclomiphene the same as clomiphene?

No. Clomiphene citrate is a mixture of two isomers, enclomiphene and zuclomiphene, roughly 62:38 ^[6]. Enclomiphene is the isomer believed responsible for most of the testosterone-raising effect; compounded enclomiphene products aim to isolate it without the zuclomiphene.

Is enclomiphene FDA-approved?

No. The Androxal program tested enclomiphene citrate in Phase III trials but the New Drug Application did not reach FDA approval ^[1][3]. What's sold today is compounded enclomiphene, prepared by a licensed compounding pharmacy under a prescription, typically under FDCA Section 503A or 503B ^[4].

Does enclomiphene preserve fertility better than TRT?

Mechanistically yes: enclomiphene raises LH and FSH, keeping testicular stimulation intact, while TRT suppresses LH/FSH and shrinks testicular function ^[1][2][7]. There isn't a large dedicated trial proving improved pregnancy rates on enclomiphene specifically, so the fertility case rests on hormonal mechanism, not a pregnancy-outcome trial.

What labs should I get if enclomiphene isn't working?

Total testosterone, free testosterone (or SHBG to calculate it), LH, FSH, estradiol, and prolactin, plus TSH if symptoms suggest thyroid involvement. The pattern across these, not testosterone alone, tells you whether the issue is dosing, product quality, or an unrelated condition.

Could a bad compounding pharmacy be the reason it's not working?

It's possible. Compounded medications aren't held to the same batch-consistency standards as FDA-approved drugs, and potency variation between compounders is a documented concern ^[4]. If labs show zero LH/FSH change at a dose that should work, an underdosed or poorly made product is a reasonable suspicion.

Can enclomiphene cause high LH and FSH but low testosterone?

Yes, and this specific pattern points to primary hypogonadism, meaning the testes can't respond adequately to LH/FSH signaling regardless of how strong that signal gets. Enclomiphene amplifies pituitary signaling; it can't repair testicular tissue that isn't producing testosterone properly.

Why do I feel worse even though my testosterone went up?

Total testosterone can normalize while free testosterone stays low if SHBG is elevated. Estradiol imbalance, unrelated thyroid or prolactin issues, and a lag between lab improvement and symptom improvement are also common. Check free T and estradiol, more than total T, before assuming the drug failed.

How much enclomiphene should I be taking?

The Androxal trials used 12.5 mg and 25 mg daily ^[1]. Most compounding protocols start around 12.5 mg and adjust based on follow-up labs. Don't self-adjust dose based on symptoms alone; changes should follow a lab-confirmed pattern, ideally with a prescriber reviewing results.

Should I switch to TRT if enclomiphene doesn't work for me?

Consider it only after 12-16 weeks at an appropriate dose, a verified product, and ruled-out primary hypogonadism, thyroid, and prolactin issues. If testosterone still won't normalize and fertility preservation isn't a priority for you, TRT is a reasonable next step to discuss with your prescriber.

Sources

1. ClinicalTrials.gov, Efficacy and Safety of Enclomiphene Citrate vs. Testosterone Gel (Androxal Phase III): Enclomiphene Phase III trial design, dosing (12.5mg/25mg), and testosterone normalization endpoints at 6/12/16 weeks
2. FDA, Drugs@FDA database search for enclomiphene/Androxal: No approved enclomiphene (Androxal) product exists in FDA's drug approval database
3. FDA, Human Drug Compounding under Sections 503A and 503B of the FD&C Act: Compounded drugs are prepared under FDCA 503A/503B and are not subject to the same premarket approval as FDA-approved drugs
4. Kelleher et al., pharmacokinetics of enclomiphene, Journal of Clinical Pharmacology: Reported half-life range for enclomiphene supporting once-daily dosing rationale
5. Wu et al., 'Clomiphene citrate isomers and their relative pharmacology,' Fertility and Sterility related review: Clomiphene citrate is a roughly 62:38 mixture of enclomiphene and zuclomiphene isomers
6. Endocrine Society, Testosterone Therapy in Men with Hypogonadism: Clinical Practice Guideline: Exogenous testosterone therapy suppresses LH/FSH and reduces spermatogenesis and testicular size